INS and dementia: Investigators discovered that the incidence of vascular disease was not significantly higher in the insulin group than in the placebo group in a clinical study examining the safety of intranasal insulin administration for the treatment of Alzheimer disease dementia, also demonstrating that intranasal insulin administration is safe (117).